Tehreen Parveen: Historical Milestone in Drug Discovery – The Discovery of Aspirin
Tehreen Parveen, Assistant Professor at RIMT University, shared a post on LinkedIn:
“Historical Milestone in Drug Discovery: The Discovery of Aspirin
Few medicines have had as profound an impact on global healthcare as aspirin.
What began as a traditional remedy derived from willow bark evolved into one of the most widely used and studied drugs in medical history. In 1897, chemist Felix Hoffmann developed a more stable and tolerable form of acetylsalicylic acid, paving the way for the medicine we know today as aspirin.
Why Aspirin Changed Medicine
- Revolutionized pain and fever management
- Became a cornerstone treatment for inflammation
- Opened new avenues in medicinal chemistry
- Continues to play a vital role in cardiovascular disease prevention
- Demonstrated how natural products can inspire transformative medicines
A Journey Through Time
- Ancient civilizations used willow bark to relieve pain and fever.
- 1828 – Salicin, the active compound, was isolated from willow bark.
- 1853 – Salicylic acid was synthesized, though it often caused stomach irritation.
- 1897 – Felix Hoffmann developed acetylsalicylic acid, creating a safer and more effective compound.
- 1899 – Aspirin was introduced commercially and went on to become one of the world’s most trusted medicines.
More than a century later, aspirin remains a powerful example of how scientific innovation can transform traditional knowledge into a medicine that improves millions of lives.
From willow bark to modern medicine, aspirin’s story is a testament to the enduring impact of drug discovery.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?